Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice

✍ Scribed by Agostino, N. M.; Chinchilli, V. M.; Lynch, C. J.; Koszyk-Szewczyk, A.; Gingrich, R.; Sivik, J.; Drabick, J. J.

• Book ID: 121838520
• Publisher: SAGE Publications
• Year: 2010
• Tongue: English
• Weight: 151 KB
• Volume: 17
• Category: Article
• ISSN: 1078-1552
• DOI: 10.1177/1078155210378913